Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/1999
11/30/1999US5994517 Homogeneous conjugate of carbohydrate ligand which binds to hepatic receptor, a bifunctional linker, and a biological stable oligonucleotide and derivative can be released from conjugate; for targeted antisense agents
11/30/1999US5994505 Forms of class II MHC transactivator (CIITA)
11/30/1999US5994503 Nucleotide and protein sequences of lats genes and methods based thereon
11/30/1999US5994317 Quaternary cytofectins
11/30/1999US5994316 Method of preparing polynucleotide-carrier complexes for delivery to cells
11/30/1999US5994315 Low adenosine agent, composition, kit and method for treatment of airway disease
11/30/1999US5994314 Compositions and methods for nucleic acid delivery to the lung
11/30/1999US5994313 Regulated apoptosis
11/30/1999US5994304 Polypeptide
11/30/1999US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999US5994136 Method and means for producing high titer, safe, recombinant lentivirus vectors
11/30/1999US5994132 Adenovirus vectors
11/30/1999US5994128 Primary cells containing a nucleic acid molecule from the adenovirus early genes, eia and eib; an encapsidating signal sequence and an inverted terminal repeat with no overlapping sequences with the target cells; autoimmune disease therapy
11/30/1999US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
11/30/1999US5994124 A protein specific to target rnas; therapy for human immunodeficiency virus
11/30/1999US5994119 Mammalian regulator of nonsense-mediated RNA decay
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994109 Nucleic acid transporter system and methods of use
11/30/1999US5994106 Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
11/30/1999US5994101 DNA encoding gidA1 polypeptides
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994096 Regulator
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993801 Gene therapy using stromal cells
11/30/1999US5993800 Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand
11/30/1999US5993799 Methods of using genetically engineered cells that produce insulin in response to glucose
11/29/1999CA2273173A1 Extension of lifespan by overexpression of a gene that increases reactive oxygen metabolism
11/25/1999WO1999060407A1 Assays, methods and means for modulating e2f activity
11/25/1999WO1999060171A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999WO1999060167A1 Compositions and methods for topical delivery of oligonucleotides
11/25/1999WO1999060166A1 Compositions and methods for the pulmonary delivery of nucleic acids
11/25/1999WO1999060164A1 Mechanical stress induced genes, expression products therefrom, and uses thereof
11/25/1999WO1999060149A1 Co-precipitates of adenovirus with metal salts
11/25/1999WO1999060148A2 Display of viral proteins as ligands for cell-surface receptor
11/25/1999WO1999060147A2 Targeted delivery through a cationic amino acid transporter
11/25/1999WO1999060146A1 Adeno-associated virus vectors and uses thereof
11/25/1999WO1999060145A1 Mutant herpes simplex viruses and uses thereof
11/25/1999WO1999060142A2 Gene therapy vectors and their use in antitumour therapy
11/25/1999WO1999060135A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999WO1999060132A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/25/1999WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999WO1999060124A2 Differentiation-associated sequences and methods of use therefor
11/25/1999WO1999060118A1 GABAA RECEPTOR ε2 SUBUNIT
11/25/1999WO1999060117A2 Prax-1 polypeptide
11/25/1999WO1999060116A1 Nucleic acid encoding protein, down-regulated in metastasis (drim), and its diagnostic and therapeutic use
11/25/1999WO1999060108A2 Transgenic animals produced by homologous sequence targeting
11/25/1999WO1999060097A1 clpX OF $i(STREPTOCOCCUS PNEUMONIAE)
11/25/1999WO1999060021A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999WO1999060019A1 HUMAN EDG3sb GENE
11/25/1999WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin
11/25/1999WO1999060012A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999WO1999060010A1 Compositions and methods for the pulmonary delivery of nucleic acids
11/25/1999WO1999060008A1 Cytosine deaminase gene
11/25/1999WO1999059639A1 Solid preparations for oral administration of drugs relating to genes
11/25/1999WO1999059622A1 Treatment for hemophilia
11/25/1999WO1999059619A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059618A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059546A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
11/25/1999WO1999049014A9 Localization and propagation of neural and neuronal progenitor cells
11/25/1999WO1999043832A3 Human proteinase molecules
11/25/1999WO1999040771A3 Concurrent flow mixing for preparing compositions comprising gene therapy vectors
11/25/1999WO1999040180A9 Expanded and genetically modified populations of human hematopoietic stem cells
11/25/1999WO1999039740A9 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
11/25/1999WO1999035495A3 Identification of substances that modify cellular secretory function
11/25/1999DE19806803A1 Transporter für Saccharid-gekoppelte Zytostatika in Tumorzellen Transportation for saccharide-linked cytotoxic agents in tumor cells
11/25/1999CA2374248A1 Gene therapy vectors and their use in antitumour therapy
11/25/1999CA2341350A1 Transgenic animals produced by homologous sequence targeting
11/25/1999CA2333144A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999CA2333087A1 Compositions and methods for the pulmonary delivery of nucleic acids
11/25/1999CA2332649A1 Solid preparations for oral administration of drugs relating to genes
11/25/1999CA2332150A1 Mechanical stress induced genes, expression products therefrom, and uses thereof
11/25/1999CA2329901A1 Assays, methods and means for modulating e2f activity
11/25/1999CA2329868A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999CA2329270A1 Targeted delivery through a cationic amino acid transporter
11/25/1999CA2329252A1 Compositions and methods for topical delivery of oligonucleotides
11/25/1999CA2329147A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
11/25/1999CA2329139A1 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999CA2329130A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999CA2328597A1 Display of viral proteins as ligands for cell-surface receptor
11/25/1999CA2328596A1 Cytosine deaminase gene
11/25/1999CA2328594A1 Mutant herpes simplex viruses and uses thereof
11/25/1999CA2328489A1 Secreted proteins and polynucleotides encoding them
11/24/1999EP0959136A1 Targeted delivery through a cationic amino acid transporter
11/24/1999EP0959135A1 Display of viral proteins and targeted delivery to cellular receptor
11/24/1999EP0958382A2 Novel method for testing the differentiation status in pancreatic cells of a mammal
11/24/1999EP0958373A1 Vaccines
11/24/1999EP0958371A2 Cytopathic viruses for therapy and prophylaxis of neoplasia
11/24/1999EP0958366A1 Human chemokine beta-13
11/24/1999EP0958364A1 Immunotherapy and improved vaccines
11/24/1999EP0958361A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
11/24/1999EP0958358A1 Method for preparing a plasmid dna
11/24/1999EP0958357A2 Novel method for testing the differentiation status in pancreatic cells of a mammal
11/24/1999EP0958356A1 A process of making a compound by forming a polymer from a template drug
11/24/1999EP0957941A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE
11/24/1999EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
11/24/1999EP0957926A1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein
11/24/1999EP0957902A1 System for genetically treating cardiac conduction disturbances
11/24/1999EP0845045A4 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors
1 ... 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 ... 870